Boothbay Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,819
| Closed | -$8.42M | – | 1639 |
|
|
2025
Q1 | $8.42M | Buy |
+63,819
| New | +$8.42M | 0.22% | 77 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1785 |
|
|
2024
Q2 | – | Sell |
-5,700
| Closed | -$394K | – | 1718 |
|
|
2024
Q1 | $394K | Buy |
+5,700
| New | +$394K | 0.01% | 952 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2126 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2251 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2380 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2248 |
|
|
2021
Q4 | – | Sell |
-19,851
| Closed | -$740K | – | 2064 |
|
|
2021
Q3 | $740K | Sell |
19,851
-19,219
| -49% | -$716K | 0.02% | 732 |
|
|
2021
Q2 | $1.6M | Hold |
39,070
| – | – | 0.05% | 412 |
|
|
2021
Q1 | $1.33M | Buy |
39,070
+2,528
| +7% | +$85.8K | 0.05% | 383 |
|
|
2020
Q4 | $1.16M | Sell |
36,542
-9,505
| -21% | -$302K | 0.04% | 366 |
|
|
2020
Q3 | $1.18M | Buy |
+46,047
| New | +$1.18M | 0.07% | 318 |
|
|
2020
Q2 | – | Sell |
-61,884
| Closed | -$951K | – | 1017 |
|
|
2020
Q1 | $951K | Buy |
+61,884
| New | +$951K | 0.08% | 271 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 940 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 848 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 836 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 820 |
|
|
2018
Q4 | – | Sell |
-17,000
| Closed | -$369K | – | 848 |
|
|
2018
Q3 | $369K | Buy |
+17,000
| New | +$369K | 0.04% | 350 |
|
|
2018
Q2 | – | Sell |
-11,300
| Closed | -$238K | – | 816 |
|
|
2018
Q1 | $238K | Buy |
+11,300
| New | +$238K | 0.03% | 443 |
|
|
2017
Q1 | – | Sell |
-12,303
| Closed | -$186 | – | 891 |
|
|
2016
Q4 | $186 | Buy |
+12,303
| New | +$186 | 0.04% | 550 |
|